Selectis Health, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GBCS research report →
Companywww.gbcsreit.com
Global Healthcare REIT, Inc. (the "Company" or "Global") was organized with the intent of operating as a real estate investment trust (REIT) for the purpose of investing in real estate and other assets related to the healthcare industry. The Company's focus has partially shifted from leasing nursing home assets to independent operators toward owning and operating its real estate assets itself.
- CEO
- Adam Desmond
- IPO
- 2004
- Employees
- 616
- HQ
- Niwot, CO, US
Price Chart
Valuation
- Market Cap
- $10.15M
- P/E
- -9.99
- P/S
- 0.24
- P/B
- -1.63
- EV/EBITDA
- 15.82
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 19.75%
- Op Margin
- -3.78%
- Net Margin
- -2.45%
- ROE
- 16.69%
- ROIC
- -8.09%
Growth & Income
- Revenue
- $41.44M · 4.94%
- Net Income
- $-1,015,752 · 58.10%
- EPS
- $-0.34 · 57.50%
- Op Income
- $-1,564,671
- FCF YoY
- 177.31%
Performance & Tape
- 52W High
- $4.58
- 52W Low
- $0.41
- 50D MA
- $4.05
- 200D MA
- $2.74
- Beta
- -1.08
- Avg Volume
- 960
Get TickerSpark's AI analysis on GBCS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 1, 26 | Desmond Adam | other | 12,500 |
| Dec 31, 25 | Desmond Adam | other | 0 |
| Jan 1, 26 | Lund Kent Jeffrey | other | 0 |
| Jan 1, 26 | Lund Kent Jeffrey | other | 0 |
| Dec 18, 25 | Baller Lance | buy | 6,192 |
| Dec 18, 23 | Creamer James W III | other | 0 |
| Oct 6, 22 | Baller Lance | buy | 400 |
| Oct 6, 22 | Baller Lance | buy | 100 |
| Jul 1, 22 | Furstenberg David J. | other | 0 |
| Jul 1, 22 | Furstenberg David J. | other | 0 |
Our GBCS Coverage
We haven't published any research on GBCS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GBCS Report →